InsidersTradesSigma
Follow the 쎌바이오텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has published 1 reports. Market capitalisation: €101.6bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 쎌바이오텍. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Cell Biotech es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de biotecnologías innovadoras.